{Reference Type}: Case Reports
{Title}: Ocular Syphilis with Retinal and Disc Neovascularization Treated with Bevacizumab: A Case Report.
{Author}: Comastri L;Heredia M;Bar D;Iribarren G;Schlaen A;
{Journal}: Case Rep Ophthalmol
{Volume}: 14
{Issue}: 1
{Year}: 2023 Jan-Dec
暂无{DOI}: 10.1159/000530876
{Abstract}: We report the findings observed in a young woman with ocular syphilis complicated with retinal and disc neovascularization successfully treated with intravitreal bevacizumab. Fluorescein angiography revealed in both eyes intense hyperfluorescence at the level of the disc, multifocal venous wall staining, multifocal paravenous leakage, multiple peripheral saccular venular dilations, diffuse retinal and macular edema, and retinal and disc neovascularization. There was no evidence of retinal ischemia in both eyes. After antibiotic and corticosteroid treatment, the neovascularization persisted in both eyes. Three consecutive doses of intravitreal bevacizumab were administered, with total regression of the retinal and disc neovascularization. Disc and retinal neovascularization along with nonocclusive retinal vasculitis may be a form of presentation of ocular syphilis. Combination of specific treatment, oral corticosteroids, and intravitreal bevacizumab may be useful for treating this clinical manifestation.